Your session is about to expire
← Back to Search
Dose Group 2 for Learning Disability
N/A
Waitlist Available
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Non-treatment-seeking community members who do not have a mental health diagnosis and individuals seeking treatment for an anxiety, mood, trauma-related, or obsessive-compulsive disorder.
Treatment and non-treatment-seeking community members with anxiety, mood, trauma-related, or obsessive-compulsive disorder or symptoms.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at 20-30, 50-60, and 80-90 minutes during stimulation
Awards & highlights
Study Summary
This trial is testing how non-invasive ear stimulation affects learning. It involves coming to MUSC in Charleston for 2.5 hours, during which researchers will measure brain waves and other body responses. There are some risks, but also the potential to help researchers improve this ear stimulation as a treatment method.
Eligible Conditions
- Learning Disability
- Transcutaneous Auricular Vagal Nerve Stimulation
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
People who are not seeking treatment for mental health conditions and those who are seeking treatment for anxiety, mood, trauma-related, or obsessive-compulsive disorders are not eligible to participate.
Select...
People with anxiety, depression, post-traumatic stress disorder (PTSD), or obsessive-compulsive symptoms who are seeking or not seeking treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured at 20-30, 50-60, and 80-90 minutes during stimulation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at 20-30, 50-60, and 80-90 minutes during stimulation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Heart Rate
Change in P300 Amplitude
Change in Skin Conductance Levels
+1 moreTrial Design
6Treatment groups
Experimental Treatment
Group I: Dose Group 6Experimental Treatment2 Interventions
Group II: Dose Group 5Experimental Treatment1 Intervention
Group III: Dose Group 4Experimental Treatment1 Intervention
Group IV: Dose Group 3Experimental Treatment2 Interventions
Group V: Dose Group 2Experimental Treatment1 Intervention
Group VI: Dose Group 1Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
taVNS 0 minutes
2022
N/A
~50
transcutaneous auricular vagus nerve stimulation (taVNS) 15 minutes
2022
N/A
~50
taVNS 30 minutes
2022
N/A
~50
taVNS 45 minutes
2022
N/A
~50
taVNS 60 minutes
2022
N/A
~50
taVNS 75 minutes
2022
N/A
~50
Find a Location
Who is running the clinical trial?
Medical University of South CarolinaLead Sponsor
929 Previous Clinical Trials
7,393,776 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger